0      0

2021 APAC Pharmaceutical Manufacturing Conference and Global Regulatory Summit

VL21CEJUN1/SESCS2 - CASE STUDY 2: Cross Contamination Controls


‐ Jun 17, 2021 4:40am

CASE STUDY 2: Cross Contamination Controls | A lab assay discovers viral residue in a product that was recently released. This plan will include an emergency response describing market action, remediation and plans to effectively communicate with regulatory authorities and customers.

Moderator(s):

You must be logged in and own this session in order to post comments.